Ivonescimab benefit for EGFR mutant NSCLC patients who failed TKI therapy
Ivonescimab benefit for EGFR mutant NSCLC patients who failed TKI therapy
Monitoring ovarian function in oncology studies
Bortezomib and dexamethasone demonstrate efficacy benefit in key subgroups vs daratumumab, bortezomib, and dexamethasone in RRMM
Blood tumour mutational burden and response to pembrolizumab plus chemotherapy in non-small cell lung cancer
Avelumab plus platinum-based chemotherapy may show some efficacy in patients with extensive-stage small cell lung cancer
Addition of atezolizumab to chemotherapy after surgery does not improve survival for triple negative breast cancer
A combined PET-MRI scan could improve treatment for patients with early breast cancer
EBCC 2024: Addressing inequalities across Europe in access to innovation for patients with metastatic breast cancer
Comment: EBCC 2024 highlights
Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours
Autovaccination with the intratumoral viral mimic poly-ICLC makes a cold tumour hot in prostate cancer
Avelumab combined with regorafenib shows improved outcome in solid tumours with tertiary lymphoid structures